Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes

Domokos Gerö, Petra Szoleczky, Athanasia Chatzianastasiou, Andreas Papapetropoulos, Csaba Szabo

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Poly(ADP-ribose) polymerase-1 (PARP-1) activation is a hallmark of oxidative stress–induced cellular injury that can lead to energetic failure and necrotic cell death via depleting the cellular nicotinamide adenine dinucleotide (NAD+) and ATP pools. Pharmacological PARP-1 inhibition or genetic PARP-1 deficiency exert protective effects in multiple models of cardiomyocyte injury. However, the connection between nuclear PARP-1 activation and depletion of the cytoplasmic and mitochondrial energy pools is poorly understood. By using cultured rat cardiomyocytes, here we report that ring finger protein 146 (RNF146), a cytoplasmic E3-ubiquitin ligase, acts as a direct interactor of PARP-1. Overexpression of RNF146 exerts protection against oxidant-induced cell death, whereas PARP-1–mediated cellular injury is augmented after RNF146 silencing. RNF146 translocates to the nucleus upon PARP-1 activation, triggering the exit of PARP-1 from the nucleus, followed by rapid degradation of both proteins. PARP-1 and RNF146 degradation occurs in the early phase of myocardial ischemia-reperfusion injury; it precedes the induction of heat shock protein expression. Taken together, PARP-1 release from the nucleus and its rapid degradation represent newly identified steps of the necrotic cell death program induced by oxidative stress. These steps are controlled by the ubiquitin-proteasome pathway protein RNF146. The current results shed new light on the mechanism of necrotic cell death. RNF146 may represent a distinct target for experimental therapeutic intervention of oxidant-mediated cardiac injury.

    Original languageEnglish
    Pages (from-to)328-331
    Number of pages4
    JournalMolecular Medicine
    Volume20
    Issue numberJULY-DECEMBER 2014
    DOIs
    StatePublished - 2014

    Fingerprint

    Finger Injuries
    Cardiac Myocytes
    Fingers
    Proteins
    Cell Death
    Wounds and Injuries
    Oxidants
    NAD
    Proteolysis
    Myocardial Reperfusion Injury
    Poly (ADP-Ribose) Polymerase-1
    Ubiquitin-Protein Ligases
    Proteasome Endopeptidase Complex
    Ubiquitin
    Heat-Shock Proteins
    Reperfusion Injury
    Myocardial Ischemia
    Oxidative Stress
    Adenosine Triphosphate
    Pharmacology

    ASJC Scopus subject areas

    • Genetics
    • Molecular Biology
    • Molecular Medicine
    • Genetics(clinical)

    Cite this

    Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes. / Gerö, Domokos; Szoleczky, Petra; Chatzianastasiou, Athanasia; Papapetropoulos, Andreas; Szabo, Csaba.

    In: Molecular Medicine, Vol. 20, No. JULY-DECEMBER 2014, 2014, p. 328-331.

    Research output: Contribution to journalArticle

    @article{82c5ade57b9e4c04b20e9d04c69298e1,
    title = "Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes",
    abstract = "Poly(ADP-ribose) polymerase-1 (PARP-1) activation is a hallmark of oxidative stress–induced cellular injury that can lead to energetic failure and necrotic cell death via depleting the cellular nicotinamide adenine dinucleotide (NAD+) and ATP pools. Pharmacological PARP-1 inhibition or genetic PARP-1 deficiency exert protective effects in multiple models of cardiomyocyte injury. However, the connection between nuclear PARP-1 activation and depletion of the cytoplasmic and mitochondrial energy pools is poorly understood. By using cultured rat cardiomyocytes, here we report that ring finger protein 146 (RNF146), a cytoplasmic E3-ubiquitin ligase, acts as a direct interactor of PARP-1. Overexpression of RNF146 exerts protection against oxidant-induced cell death, whereas PARP-1–mediated cellular injury is augmented after RNF146 silencing. RNF146 translocates to the nucleus upon PARP-1 activation, triggering the exit of PARP-1 from the nucleus, followed by rapid degradation of both proteins. PARP-1 and RNF146 degradation occurs in the early phase of myocardial ischemia-reperfusion injury; it precedes the induction of heat shock protein expression. Taken together, PARP-1 release from the nucleus and its rapid degradation represent newly identified steps of the necrotic cell death program induced by oxidative stress. These steps are controlled by the ubiquitin-proteasome pathway protein RNF146. The current results shed new light on the mechanism of necrotic cell death. RNF146 may represent a distinct target for experimental therapeutic intervention of oxidant-mediated cardiac injury.",
    author = "Domokos Ger{\"o} and Petra Szoleczky and Athanasia Chatzianastasiou and Andreas Papapetropoulos and Csaba Szabo",
    year = "2014",
    doi = "10.2119/molmed.2014.00102",
    language = "English",
    volume = "20",
    pages = "328--331",
    journal = "Molecular Medicine",
    issn = "1076-1551",
    publisher = "Feinstein Institute for Medical Research",
    number = "JULY-DECEMBER 2014",

    }

    TY - JOUR

    T1 - Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes

    AU - Gerö, Domokos

    AU - Szoleczky, Petra

    AU - Chatzianastasiou, Athanasia

    AU - Papapetropoulos, Andreas

    AU - Szabo, Csaba

    PY - 2014

    Y1 - 2014

    N2 - Poly(ADP-ribose) polymerase-1 (PARP-1) activation is a hallmark of oxidative stress–induced cellular injury that can lead to energetic failure and necrotic cell death via depleting the cellular nicotinamide adenine dinucleotide (NAD+) and ATP pools. Pharmacological PARP-1 inhibition or genetic PARP-1 deficiency exert protective effects in multiple models of cardiomyocyte injury. However, the connection between nuclear PARP-1 activation and depletion of the cytoplasmic and mitochondrial energy pools is poorly understood. By using cultured rat cardiomyocytes, here we report that ring finger protein 146 (RNF146), a cytoplasmic E3-ubiquitin ligase, acts as a direct interactor of PARP-1. Overexpression of RNF146 exerts protection against oxidant-induced cell death, whereas PARP-1–mediated cellular injury is augmented after RNF146 silencing. RNF146 translocates to the nucleus upon PARP-1 activation, triggering the exit of PARP-1 from the nucleus, followed by rapid degradation of both proteins. PARP-1 and RNF146 degradation occurs in the early phase of myocardial ischemia-reperfusion injury; it precedes the induction of heat shock protein expression. Taken together, PARP-1 release from the nucleus and its rapid degradation represent newly identified steps of the necrotic cell death program induced by oxidative stress. These steps are controlled by the ubiquitin-proteasome pathway protein RNF146. The current results shed new light on the mechanism of necrotic cell death. RNF146 may represent a distinct target for experimental therapeutic intervention of oxidant-mediated cardiac injury.

    AB - Poly(ADP-ribose) polymerase-1 (PARP-1) activation is a hallmark of oxidative stress–induced cellular injury that can lead to energetic failure and necrotic cell death via depleting the cellular nicotinamide adenine dinucleotide (NAD+) and ATP pools. Pharmacological PARP-1 inhibition or genetic PARP-1 deficiency exert protective effects in multiple models of cardiomyocyte injury. However, the connection between nuclear PARP-1 activation and depletion of the cytoplasmic and mitochondrial energy pools is poorly understood. By using cultured rat cardiomyocytes, here we report that ring finger protein 146 (RNF146), a cytoplasmic E3-ubiquitin ligase, acts as a direct interactor of PARP-1. Overexpression of RNF146 exerts protection against oxidant-induced cell death, whereas PARP-1–mediated cellular injury is augmented after RNF146 silencing. RNF146 translocates to the nucleus upon PARP-1 activation, triggering the exit of PARP-1 from the nucleus, followed by rapid degradation of both proteins. PARP-1 and RNF146 degradation occurs in the early phase of myocardial ischemia-reperfusion injury; it precedes the induction of heat shock protein expression. Taken together, PARP-1 release from the nucleus and its rapid degradation represent newly identified steps of the necrotic cell death program induced by oxidative stress. These steps are controlled by the ubiquitin-proteasome pathway protein RNF146. The current results shed new light on the mechanism of necrotic cell death. RNF146 may represent a distinct target for experimental therapeutic intervention of oxidant-mediated cardiac injury.

    UR - http://www.scopus.com/inward/record.url?scp=84921926048&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84921926048&partnerID=8YFLogxK

    U2 - 10.2119/molmed.2014.00102

    DO - 10.2119/molmed.2014.00102

    M3 - Article

    VL - 20

    SP - 328

    EP - 331

    JO - Molecular Medicine

    JF - Molecular Medicine

    SN - 1076-1551

    IS - JULY-DECEMBER 2014

    ER -